In women with severe postpartum depression, zuranolone was associated with improvements in depression beginning at day 3. FDA to make a decision next week.

The post More Data on Zuranolone for Postpartum Depression: When Will It Hit the Market? appeared first on MGH Center for Women’s Mental Health.